1. Home
  2. ONDS vs APGE Comparison

ONDS vs APGE Comparison

Compare ONDS & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ondas Holdings Inc.

ONDS

Ondas Holdings Inc.

HOLD

Current Price

$9.07

Market Cap

4.6B

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$89.91

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONDS
APGE
Founded
2014
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.7B
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
ONDS
APGE
Price
$9.07
$89.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
13
Target Price
$19.83
$109.67
AVG Volume (30 Days)
69.8M
1.0M
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.56
N/A
Revenue
$50,731,000.00
N/A
Revenue This Year
$662.14
N/A
Revenue Next Year
$76.37
N/A
P/E Ratio
$16.46
N/A
Revenue Growth
605.31
N/A
52 Week Low
$1.36
$34.34
52 Week High
$15.28
$95.32

Technical Indicators

Market Signals
Indicator
ONDS
APGE
Relative Strength Index (RSI) 42.78 58.46
Support Level $8.43 $73.70
Resistance Level $11.87 $93.61
Average True Range (ATR) 0.89 5.02
MACD -0.26 0.62
Stochastic Oscillator 6.10 89.73

Price Performance

Historical Comparison
ONDS
APGE

About ONDS Ondas Holdings Inc.

Ondas Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system. Geographically, the company operates in Israel, Germany, United Arab Emirates, United States, and Other Countries. It derives maximum revenue from Israel.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: